Patient info Open main menu

FOSRENOL® 500 mg chewable tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
500 mg
Contains active substance:

Patient leaflet - Fosrenol 500 mg chewable tablets

1. What Fosrenol is and what it is used for

Fosrenol is used to lower the phosphate level in the blood of adult patients with chronic kidney disease.

Patients who have kidneys that do not work properly are not able to control the level of phosphate in the blood. The amount of phosphate in the blood then rises (your doctor may call this hyperphosphataemia).

Fosrenol is a medicine which reduces the body’s absorption of phosphate from food by binding with it in your digestive tract. Phosphate which has bonded to Fosrenol cannot be absorbed through the intestinal wall.

2. What you need to know before you take Fosrenol

Do not take Fosrenol

  • if you are allergic to lanthanum carbonate hydrate or any of the other ingredients of this medicine (listed in section 6)
  • if you have too little phosphate in your blood (hypophosphataemia)
  • if you have blockage of the bowel (bowel obstruction).

Warnings and precautions

Talk to your doctor or pharmacist before taking Fosrenol if you know that you have, or have had, any of the following:

  • stomach or intestinal cancer
  • inflammatory bowel disease including ulcerative colitis or Crohn’s disease
  • abdominal surgery, or infection or inflammation of the abdomen/bowel (peritonitis)
  • stomach or intestinal ulcers
  • blockage of the intestine or slow motility (movement) in the intestine (e.g., constipation and stomach complications due to diabetes)
  • reduced liver or kidney function.

It is very important to chew completely Fosrenol and not to swallow them whole or incompletely chewed. This will reduce the risk of adverse gastrointestinal complications like rupture in the intestine wall, blockage in the intestine, constipation (see section 4).

If you have reduced kidney function, your doctor may decide to check the level of calcium in your blood from time to time. If you have too little calcium, you may then be given extra calcium.

If you need to have an X-ray, please inform your doctor that you are taking Fosrenol as it may affect the results.

If you need to have a gastrointestinal endoscopy, please inform your doctor that you are taking Fosrenol because the endoscopist might detect lanthanum deposits in the digestive tract.

Other medicines and Fosrenol

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Fosrenol can affect how certain medicines are absorbed from your digestive tract. If you are taking chloroquine (for rheumatism and malaria), ketoconazole (for fungal infections), tetracycline or doxycycline antibiotics they should not be taken within 2 hours before or after taking Fosrenol.

It is not recommended that you take oral floxacin antibiotics (including ciprofloxacin) within 2 hours before or 4 hours after taking Fosrenol.

If you are taking levothyroxine (for an underactive thyroid) it should not be taken within 2 hours before or after taking Fosrenol. Your doctor may want to monitor the levels of thyroid-stimulating hormone (TSH) in your blood more closely.

Fosrenol with food and drink

Fosrenol should be taken with, or immediately after food. See section 3 for instructions on how to take Fosrenol.

Pregnancy and breast-feeding

Fosrenol should not be taken during pregnancy. If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

As it is not known whether the medicine can be transferred to a child in breast milk, you should not breast-feed whilst taking Fosrenol. If you are breast-feeding, ask your doctor or pharmacist for advice before taking any medicines.

Driving and using machines

Dizziness and vertigo (a feeling of dizziness or “spinning”) are uncommon side effects reported by patients taking Fosrenol. If you experience these side effects, it may affect your ability to drive or operate machines.

Fosrenol contains glucose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

3. How to take Fosrenol

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

You should take Fosrenol with, or immediately after food. Side effects such as nausea and vomiting are more likely if you take Fosrenol before your meal.

The tablets must be chewed completely and not swallowed whole. To aid with chewing, the tablets may be crushed. Additional fluid is not necessary. If you find chewing the tablets difficult, talk to your doctor as an oral powder form of this medicine is available.

Your doctor will tell you how many tablets you must take with each meal (your daily dose will be divided between meals). The number of tablets that you take will depend on:

  • Your diet (the amount of phosphate in the food you eat)
  • Your blood phosphate level

To start with, the daily dose of Fosrenol will usually be 1 tablet with each meal (3 tablets per day).

Every 2-3 weeks your doctor will check the level of phosphate in your blood and may increase your dose until the level of phosphate in your blood is acceptable.

Fosrenol works by binding phosphate from the food in your gut. It is very important to take Fosrenol at every meal. If you change your diet, contact your doctor as you may need to take extra Fosrenol. Your doctor will tell you what to do in this case.

If you take more Fosrenol than you should

If you take too many tablets contact your doctor to assess the risk and obtain advice. Symptoms of overdose may be nausea and headaches.

If you forget to take Fosrenol

It is important to take Fosrenol with every meal.

If you forget to take your Fosrenol, then take the next dose with your next meal. Do not take a double dose to make up for a forgotten dose.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some side effects could be serious. If you get any of the following side effects, seek immediate medical attention:

  • Rupture in the intestinal wall (signs include: severe stomach pain, chills, fever, nausea, vomiting, or a tender abdomen). This is a rare side effect (may affect up to 1 in 1,000 people).
  • Blockage in the intestine (signs include: severe bloating; abdominal pain, swelling or cramps; severe constipation). This is an uncommon side effect (may affect up to 1 in 100 people).
  • Contact your doctor if you have new or severe constipation, it could be an early sign of blockage in your intestine. Constipation is a common side effect (may affect 1 in 10 people).

Other less serious side effects include the following:

Very common side effects (may affect more than 1 in 10 people):

  • Nausea, vomiting, diarrhoea, stomach pain, headache, itching, rash.

Common side effects (may affect up to 1 in 10 people):

  • Heartburn, flatulence.
  • Hypocalcaemia (too little calcium in your blood) is also a common side effect; the symptoms of which can include tingling in the hands and feet, muscle and abdominal cramps or spasms of the facial and feet muscles.

604-9472 L-03-2452-01

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Uncommon side effects (may affect up to 1 in 100 people):

  • Tiredness; feeling of discomfort; chest pain, weakness; swollen hands and feet; body pain; dizziness; vertigo; belching; inflammation of the stomach and intestines (gastroenteritis); indigestion; irritable bowel syndrome; dry mouth; tooth disorders; inflammation of the gullet or mouth; loose stools; increases in certain liver enzymes, parathyroid hormone; aluminium, calcium and glucose in the blood; increased or reduced phosphate level in the blood; thirst; weight decrease; joint pain; muscle pain; weakness and thinning of the bones (osteoporosis); lack of and increased appetite; inflammation of the larynx; loss of hair; increased sweating; taste disturbance and increased white blood cell count.

Not known (frequency cannot be estimated from the available data):

  • Product residue present in digestive tract

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Fosrenol

Keep out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the carton and the bottle label after ‘EXP’. The expiry date refers to the last day of that month.

If your medicine shows any signs of deterioration or discolouration, please consult your doctor or pharmacist for advice. If damaged, please tell your doctor or pharmacist.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away any medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Fosrenol contains

  • The active substance is lanthanum (as lanthanum carbonate hydrate). Each chewable tablet contains 500 mg lanthanum.
  • The other ingredients are dextrates (hydrated), colloidal anhydrous silica and magnesium stearate.

What Fosrenol looks like and contents of the pack

Fosrenol is a white, round, flat tablets with a bevelled edge, engraved with ‘S405/500’ on one side and plain on the reverse.

The tablets are supplied in plastic bottles of multipacks containing

90 (2 packs of 45) chewable tablets.

Manufactured by: Hamol Limited, Nottingham site, Thane Road, Nottingham, Nottinghamshire, NG90 2DB, UK or RB NL Brands B.V., Schiphol Boulevard 207, 1118BH, Schiphol, The Netherlands.

Procured from within the EU. Product Licence Holder: Quadrant Pharmaceuticals Limited, Lynstock House, Lynstock Way, Lostock, Bolton, BL6 4SA. Repackaged by: Maxearn Limited, Unit 29, Oakhill Trading Estate, Devonshire Road, Worsley, Manchester, M28 3PT.

PL 20774/2452 - FOSRENOL 500 mg chewable tablets

FOSRENOL is a registered trademark of Takeda Pharmaceuticals U.S.A., Inc.

Date of preparation: 2nd June 2025

Blind or partially sighted?

Is this leaflet hard to see or read?

Contact Quadrant Pharmaceuticals Ltd, Tel: 01204 471 269

604-9472 L-03-2452-01

POM

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 20774/2452

Last revision stated in the text: 2 June 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Fosrenol 500 mg chewable tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Lanthanum carbonate
Strength 500 mg
Pharmaceutical form Chewable tablet
How is it taken Oral
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. V Various drug classes
    1. V03 All other therapeutic products
      1. V03A All other therapeutic products
        1. V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
          1. V03AE03 lanthanum carbonate
Marketing authorisation PLPI 20774/2452
Codes BNF 09050202

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.